Mantiscope

Ankara, Turkey  All Turkey companies → — Founded 2018
Point-of-Care Diagnostics Specialty-Focused AI
Hematology Laboratory Medicine Pathology
Lab & Diagnostics Pathology AI
Accelerator/Incubator, Seed Round
Website Claim this company

Products

Mantiscope
Mantiscope
Lab & Diagnostics
Mantiscope is an IVD system that digitizes biological slides and uses AI for automatic red and white blood cell classification, abnormality detection, and percentage calculation from smear images. It also includes a laboratory management system and tele-pathology features.
Contact for demo

See all 1 product →

About Mantiscope

Mantiscope is a healthcare AI company that has developed an in-vitro diagnostic (IVD) system to automate and enhance blood cell analysis. The system comprises an automated scanner that digitizes biological slides and a cloud-based AI platform for examining smear samples. This technology aims to streamline diagnostics, improve accuracy, and accelerate blood cell analysis workflows for laboratories and healthcare providers.

The company’s primary focus is to address the disparity in diagnostic services, particularly in rural and underserved areas where access to expert hematologists and well-equipped laboratories may be limited. Mantiscope’s platform offers automated red and white blood cell classification (identifying up to 60 types of cell patterns), abnormality detection, and the ability to flag risky smear samples. The system also includes a tele-pathology feature, allowing physicians to remotely access and control the hardware for real-time diagnosis, and an annotation platform for physicians to edit AI recommendations, fostering an agile and updatable AI in the cloud. Mantiscope’s solution is designed to reduce the time physicians spend on non-risky patients and facilitate quicker diagnoses, which is crucial for conditions like leukemia.

Focus Areas

blood cell analysis artificial intelligence digital pathology hematology in-vitro diagnostics cloud computing IoT tele-pathology laboratory management systems

Business Intelligence

TechnologyCloud-based AI system, automated scanner, IoT integration, annotation platform for physician feedback

What Physicians Need to Know

Specialization: Blood Disease Diagnostics
Mantiscope specializes in AI-powered blood smear analysis for the detection and classification of various blood diseases, including leukemia. They focus on red and white blood cell classification (up to 60 cell patterns), abnormality detection, and calculating percentages of WBC and RBC.
Target Audience: Underserved & Rural Areas
A key differentiator for Mantiscope is its focus on providing advanced diagnostic capabilities to rural and suburban areas, and places lacking expert hematologists. Their cloud-based system allows costly AI-based systems to be centralized while distributing affordable scanners to these areas.
Technology Stack: Cloud-based IVD System with AI & IoT
Mantiscope's core technology is an In-Vitro Diagnostics (IVD) system comprising a scanner and a cloud-based AI. The scanner digitizes biological slides and uploads images to the cloud, where AI examines smear samples. The system also incorporates IoT for connectivity and an annotation platform for physicians to refine AI recommendations, creating an agile and updatable AI.
Key Differentiator: Remote Collaboration & Accessibility
Mantiscope offers remote collaboration capabilities, allowing physicians to access and control the device and provide diagnoses from anywhere globally through a web-based platform. This addresses the challenge of limited access to specialists in remote locations.
Efficiency: Rapid Diagnosis & Reduced Workload
The system aims to significantly reduce diagnosis times, particularly for critical diseases like leukemia, from several days to the same day. It helps physicians by pre-classifying cells and highlighting risky samples, thereby saving time and streamlining the diagnostic workflow.
Physician Tip

For physicians, Mantiscope offers a powerful tool to enhance diagnostic accuracy and efficiency, especially in settings with limited access to hematology experts. The AI-driven pre-analysis of blood smears, including classification of up to 60 cell patterns and abnormality detection, can significantly reduce the manual workload and accelerate the diagnostic process for diseases like leukemia. The cloud-based nature and tele-pathology system enable remote consultation and collaboration, allowing for expert opinions on challenging cases regardless of geographical location. Furthermore, the annotation platform allows physicians to contribute to and refine the AI's learning, ensuring the system remains agile and continuously improves. This can lead to earlier interventions and improved patient outcomes, particularly in time-sensitive conditions.

Mantiscope's system is designed as an IVD system with a scanner and cloud-based AI. While specific third-party integrations are not explicitly detailed, the cloud-based platform and laboratory management system suggest potential for integration with existing hospital information systems (HIS) or electronic health records (EHR) for seamless patient data management and report sharing. The ability to share smear sample images via URL also facilitates easy collaboration with other experts.

Products by Mantiscope

1 product in the directory

Mantiscope
Mantiscope
Lab & Diagnostics
Mantiscope is an IVD system that digitizes biological slides and uses AI for automatic red and white blood cell classification, abnormality detection, and percentage calculation from smear images. It also includes a laboratory management system and tele-pathology features.
Contact for demo

Reviews & Opinions

No web reviews on file yet for Mantiscope. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Mantiscope.

Loading videos...

Videos load interactively. If none appear, search YouTube for Mantiscope →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Mantiscope offers an IVD system that includes a scanner and a cloud-based AI for blood cell analysis, specifically for peripheral blood smears and bone marrow aspirations. This system digitizes biological slides, classifies red and white blood cells (identifying 60 types of cell patterns), detects abnormalities, and flags risky samples. For physicians, it provides an AI assistant for faster and more accurate diagnoses, and an annotation platform to edit AI recommendations, making the AI agile and updatable. For administrators, it offers a laboratory management system for online workflow, patient/physician/report management, and tele-pathology capabilities for remote diagnosis and expert collaboration, aiming to improve efficiency and access to diagnostics, especially in areas lacking specialists.
Mantiscope's system uploads images to the cloud by hashing the patient's barcode, indicating a focus on data anonymization or pseudonymization. While specific details on their HIPAA and GDPR compliance are not extensively detailed, healthcare AI systems generally must adhere to these regulations, which involve robust data privacy and security measures, transparent processes for AI decisions, and accountability structures. Mantiscope's cloud-based nature and focus on data management suggest these are critical considerations.
Mantiscope's website does not publicly list specific pricing for its IVD system. However, their approach of centralizing the costly AI in the cloud and distributing hardware scanners in rural areas suggests a model designed to be more cost-effective than high-cost automation for well-equipped hospitals. For detailed pricing, it would be necessary to contact Mantiscope directly for a demo or a quote.
Mantiscope provides an annotation platform that allows physicians to edit AI recommendations, which also contributes to an agile and updatable AI system. While specific details on dedicated customer support channels or formal training programs are not explicitly outlined, the company emphasizes collaboration and development of new decision support systems, suggesting a hands-on approach to user engagement and system refinement.
Mantiscope has engaged in collaborations with hematology professors and has been involved in pilot tests at hospitals in Turkey and at Hospital Clínic de Barcelona. They have also received investment from organizations like G4A, Big Bang | Startup Challenge, and S2 Xpeed. Mantiscope encourages contact for collaboration and development of new decision support systems.
Mantiscope was founded in 2018 and is a privately held company headquartered in Ankara, Turkey, with an Asia-Pacific representative office in Tokyo, Japan. They have received a European Commission Seal of Excellence and a TÜBu0130TAK 1507 Research and Development Grant. Mantiscope's vision is to make timely and accurate blood disease diagnoses accessible to all, especially in rural areas, by providing cost-effective, cloud-based AI solutions, aiming to prevent blood cancer deaths worldwide.
Mantiscope offers a laboratory management system that allows for online work, including inserting patients, physicians, and test reports, and sharing reports with other physicians. The system is designed to digitize biological samples and upload images to the cloud by hashing patient barcodes, suggesting an interface for data input. While direct integration with specific EHR systems isn't detailed, the platform's focus on managing laboratory workflows and sharing reports implies a capability to interact with broader healthcare IT ecosystems.

Related Companies

Pe
Perimeter Medical Imaging AI
Toronto, Canada and Dallas, Texas, USA

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS
Rolle, Switzerland and Boston, Massachusetts, United States

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
DeepBio
Seoul, South Korea

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
AIRA Matrix
Thane, Maharashtra, India

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
AI-LabTest

AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]
Google DeepMind
London, United Kingdom, with research centers in the United States, Canada, France, Germany, and Switzerland. The London headquarters is located at Platform 37, Kings Cross Central.

Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.